Rafina Innovations (VICA) Return on Equity ROE from the first quarter 2019 to first quarter 2018 and annually, average high and low, overall ranking from Mar 31 2019 to Mar 31 2018 - CSIMarket
CSIMarket
 


Rafina Innovations Inc.  (VICA)

Rafina Innovations's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Rafina Innovations in the first quarter 2019?
Due to the lack of equity, it was not possible to calculate Rafina Innovations Inc.'s return on equity (ROE) in its first quarter 2019

What is ROE?




Return On Equity (Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -6 -6 -5 -5 -3
Return On Equity (TTM) - - - - -
VICA's Total Ranking # # # # #
Equity (TTM) in Millions -1 0 0 0 -1
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





VICA Annual Return On Equity (Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
(Dec 31 2015)
2015
(Dec 31 2014)
2014
Total Equity in Millions 0 -1 -1 -1 0
Y / Y Equity Change - - - - -
Net Income in Millions -6 -3 -2 -9 -19
Y / Y Net Income Change - - - - -
Return On Equity - - - - -





More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
VICA's' Return on Equity at Yahoo Finance
VICA's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for VICA's Competitors
Subscribers only: Roe for Rafina Innovations's Suppliers
Subscribers only: Return On Equity for VICA's Customers




Companies with similar Return On Equity at Mar 31 2019, within Healthcare Sector ROE
Neuropathix Inc.  2,315.90 %
Alimera Sciences Inc  2,195.81 %
Innoviva Inc   1,745.13 %
Generex Biotechnology Corp  1,244.18 %
Zomedica Corp   1,110.36 %
Ampio Pharmaceuticals inc   758.28 %
Tuhura Biosciences Inc   439.58 %
Tenax Therapeutics Inc   263.35 %


Date modified: 2026-09-18T14:07:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.